These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8296814

  • 1. A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I, Hedner N, Mannheimer C.
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):123-9. PubMed ID: 8296814
    [Abstract] [Full Text] [Related]

  • 2. The effect of flurbiprofen and naproxen sodium on intra-uterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I, Andersch B, Sundell G.
    Acta Obstet Gynecol Scand; 1988 Jan; 67(8):711-6. PubMed ID: 3074603
    [Abstract] [Full Text] [Related]

  • 3. Effect of ibuprofen, naproxen sodium and paracetamol on intrauterine pressure and menstrual pain in dysmenorrhoea.
    Milsom I, Andersch B.
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1129-35. PubMed ID: 6388624
    [Abstract] [Full Text] [Related]

  • 4. Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure.
    Henzl MR, Ortega-Herrera E, Rodriguez C, Izu A.
    Am J Obstet Gynecol; 1979 Oct 15; 135(4):455-60. PubMed ID: 484644
    [Abstract] [Full Text] [Related]

  • 5. A rationale for the treatment of dysmenorrhea.
    Csapo AI.
    J Reprod Med; 1980 Oct 15; 25(4 Suppl):213-21. PubMed ID: 7001020
    [Abstract] [Full Text] [Related]

  • 6. Suppression of uterine activity by prostaglandin synthetase inhibitors.
    Pulkkinen MO.
    Acta Obstet Gynecol Scand Suppl; 1979 Oct 15; 87():39-43. PubMed ID: 111465
    [Abstract] [Full Text] [Related]

  • 7. Interrelation of analgesia and uterine activity in women with primary dysmenorrhea. A preliminary report.
    Smith RP, Heltzel JA.
    J Reprod Med; 1991 Apr 15; 36(4):260-4. PubMed ID: 2072357
    [Abstract] [Full Text] [Related]

  • 8. The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients.
    Csapo AI, Pulkkinen MO, Henzl MR.
    Prostaglandins; 1977 Jan 15; 13(1):193-9. PubMed ID: 320630
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of transcutaneous electrical nerve stimulation and interferential current in primary dysmenorrhea.
    Tugay N, Akbayrak T, Demirtürk F, Karakaya IC, Kocaacar O, Tugay U, Karakaya MG, Demirtürk F.
    Pain Med; 2007 Jan 15; 8(4):295-300. PubMed ID: 17610451
    [Abstract] [Full Text] [Related]

  • 10. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S, Robbins J, West CR, Nemeth MA.
    Clin Ther; 2009 Jun 15; 31(6):1192-208. PubMed ID: 19695387
    [Abstract] [Full Text] [Related]

  • 11. Abdominal skeletal muscle activity precedes spontaneous menstrual cramping pain in primary dysmenorrhea.
    Oladosu FA, Tu FF, Farhan S, Garrison EF, Steiner ND, Roth GE, Hellman KM.
    Am J Obstet Gynecol; 2018 Jul 15; 219(1):91.e1-91.e7. PubMed ID: 29733841
    [Abstract] [Full Text] [Related]

  • 12. Transcutaneous electrical nerve stimulation (TENS) for the treatment of primary dysmenorrhea: a randomized crossover comparison with placebo TENS and ibuprofen.
    Dawood MY, Ramos J.
    Obstet Gynecol; 1990 Apr 15; 75(4):656-60. PubMed ID: 2179780
    [Abstract] [Full Text] [Related]

  • 13. The role of transcutaneous electrical nerve stimulation for menstrual pain relief: A randomized control trial.
    McLagan B, Dexheimer J, Strock N, Goldstein S, Guzman S, Erceg D, Schroeder ET.
    Womens Health (Lond); 2024 Apr 15; 20():17455057241266455. PubMed ID: 39066557
    [Abstract] [Full Text] [Related]

  • 14. Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists.
    Ekström P, Juchnicka E, Laudanski T, Akerlund M.
    Contraception; 1989 Jul 15; 40(1):39-47. PubMed ID: 2505970
    [Abstract] [Full Text] [Related]

  • 15. The New Portable Transcutaneous Electrical Nerve Stimulation Device Was Efficacious in the Control of Primary Dysmenorrhea Cramp Pain.
    Lauretti GR, Oliveira R, Parada F, Mattos AL.
    Neuromodulation; 2015 Aug 15; 18(6):522-6; discussion 522-7. PubMed ID: 25655828
    [Abstract] [Full Text] [Related]

  • 16. Transcutaneous electrical nerve stimulation in the relief of primary dysmenorrhea.
    Lewers D, Clelland JA, Jackson JR, Varner RE, Bergman J.
    Phys Ther; 1989 Jan 15; 69(1):3-9. PubMed ID: 2783493
    [Abstract] [Full Text] [Related]

  • 17. A randomized clinical trial of the effectiveness of an acupressure device (relief brief) for managing symptoms of dysmenorrhea.
    Taylor D, Miaskowski C, Kohn J.
    J Altern Complement Med; 2002 Jun 15; 8(3):357-70. PubMed ID: 12165194
    [Abstract] [Full Text] [Related]

  • 18. The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study.
    Pirhonen J, Pulkkinen M.
    Acta Obstet Gynecol Scand; 1995 Aug 15; 74(7):549-53. PubMed ID: 7618455
    [Abstract] [Full Text] [Related]

  • 19. Ultrasound and magnetic resonance imaging-based investigation of the role of perfusion and oxygen availability in menstrual pain.
    Cockrum RH, Tu FF, Kierzkowska O, Leloudas N, Pottumarthi PV, Hellman KM.
    Am J Obstet Gynecol; 2024 May 15; 230(5):553.e1-553.e14. PubMed ID: 38295969
    [Abstract] [Full Text] [Related]

  • 20. Intra-uterine pressure in dysmenorrhea.
    Lumsden MA, Baird DT.
    Acta Obstet Gynecol Scand; 1985 May 15; 64(2):183-6. PubMed ID: 3984694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.